BOTHELL, Wash., Dec. 21 /PRNewswire-FirstCall/ -- Cardiac Science Corporation, , a leading provider of cardiac monitoring, defibrillation and rehabilitative products, announced that it completed the connectivity of its HeartCentrix(R) ECG informatics software with Greenway Medical Technology’s PrimeSuite(R) electronic medical record (EMR) solution.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO)
Connecting Cardiac Science’s Burdick(R) and Quinton(R) brand ECG, exercise stress, and Holter devices with Greenway’s PrimeSuite solution will help physicians to streamline the diagnostic cardiology workflow in their offices, eliminating a source of data transcription errors and providing the physician with a unified view of patient diagnostic data. With HeartCentrix ECG informatics, physicians have immediate access to electronically view or edit a patient’s test results and later retrieve the data from PrimeSuite.
“With the success of this connectivity solution, Greenway(R) customers with Burdick and Quinton brand ECG, stress and Holter devices will now be able to significantly enhance the workflow associated with ordering and reviewing patient tests,” said Greg Newman, director, product management, Cardiac Science Corporation. “The combination of our respected cardiac monitoring products with Greenway’s leading electronic health record (EHR) solution enables us to offer physicians an extremely efficient, easy and timely means to access critical patient information.”
“By implementing interoperability between PrimeSuite and HeartCentrix ECG informatics, physicians will be impressed with the efficiency and functionality PrimeSuite adds to their practice and daily workflow,” added Justin Barnes, vice president of marketing and government affairs for Greenway. “Many of our customers rely on Burdick and Quinton diagnostic devices, and we are pleased that they can bring these devices onto their PrimeSuite integrated platform to improve patient care, patient satisfaction and practice revenue.”
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor defibrillators and cardiology data management systems. The Company sells a variety of related products and consumables, and provides a portfolio of training, maintenance and support services. The successor to various entities that owned and operated cardiac businesses under the trusted Burdick(R), Powerheart(R), Quinton(R) and HeartCentrix(R) brand names, Cardiac Science is headquartered in Bothell, WA, and has operations in California and Wisconsin, China, Denmark, France and the United Kingdom.
Frost & Sullivan, the global growth consulting company, awarded Cardiac Science its 2007 award for Global Excellence in ECG Monitoring, recognizing Cardiac Science’s superior leadership and vision to provide superior healthcare solutions in the cardiac monitoring market.
About Greenway Medical Technologies, Inc.
Greenway Medical Technologies provides the latest in ambulatory healthcare business solutions by enhancing the delivery of patient care through innovative software and services that allow physician practices to function at their highest level of efficiency. Greenway’s PrimeSuite serves as the starting point of a long-term business plan for physician practices as an Ambulatory Software suite with CCHIT Certified(SM) integrated EHR practice management and interoperability functionality. With PrimeSuite integrating a practice’s clinical, financial, and administrative processes, practices can increase profitability, enhance patient satisfaction, and facilitate adherence to compliance guidelines. Established in 1998, Carrollton, Ga. - based Greenway Medical Technologies is a privately held company with more than 225 employees. For more information about Greenway, visit http://www.greenwaymedical.com.
Forward Looking Statements
This press release contains forward-looking statements. The words “believe,” “expect,” “intend,” anticipate,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward looking statements in this press release include those that infer or imply that the revenue and profits of Cardiac Science may increase as a result of the connectivity of its products with those of Greenway Medical Technologies. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the 10-k filed by Cardiac Science Corporation for the year ended December 31, 2006 and other documents filed by Cardiac Science with the Securities & Exchange Commission. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
CONTACT: Company Contact, Mike Matysik, Sr. Vice President and CFO of
Cardiac Science Corporation, +1-425-402-2009; or investors, Douglas Sherk
or Jenifer Kirtland, +1-415-896-6820, or media, Steve DiMattia,
+1-646-201-5445, all of EVC Group, Inc., for Cardiac Science Corporation
Web site: http://www.cardiacscience.com/
http://www.greenwaymedical.com/
